Connexion
E-mail
Mot de passe
Afficher le mot de passe
Retenir
Mot de passe oublié ?
Devenir membre gratuitement
Inscription
Inscription
Devenir membre
Inscription gratuite
Devenir client
Découvrez nos services
Paramètres
Paramètres
Cotations dynamiques 
OFFON

SAMSUNG BIOLOGICS CO.,LTD.

(A207940)
  Rapport
SynthèseGraphiquesActualitésNotationsAgendaSociétéFinancesConsensusRévisionsFondsCommunauté 
SynthèseToute l'actualitéReco analystesAutres languesCommuniquésPublications officiellesActualités du secteur
Actualités dans d'autres langues sur SAMSUNG BIOLOGICS CO.,LTD.
14/01South Korean Stocks Fall for Second Day as Bank of Korea Raises Base Rate; Samsung Biol..
14/01Samsung Biologics to Start Building Fifth Plant to Meet Higher Biopharmaceutical Produc..
13/01S.Korean stocks end lower on options expiry; BOK in focus
12/01South Korean Stocks Jump After US Fed Chief’s Less Hawkish Testimony; Hanmi Pharm..
12/01S.Korean stocks post best day in 6 weeks on Powell remarks
03/01S.Korea stocks begin 2022 with mild gains on trade data boost
2021Wall Street closes down, indexes still poised for big annual gains
2021Samsung BioLogics says report on Biogen deal talks untrue
2021Dow touches record high as unemployment claims slip
2021Biogen Shares Give Up Gains as Samsung Denies Takeover Rumor
2021MÄRKTE ASIEN/China-Börsen trotzen dem Negativtrend an Börsen
2021Samsung weist Medienbericht über milliardenschwere Übernahme von Biogen zurück
2021MÄRKTE Asien/Schanghai auf Erholungskurs - Sonst eher Abschläge
2021SOUTH KOREA'S PRIMARY BENCHMARK KOSP : Nomura
2021S.Korea stocks end higher as Fed decision calms nerves
2021South Korean Stocks Decline Ahead of US Fed’s Policy Decision; Samsung Biologics ..
2021Samsung Biologics to Produce AstraZeneca's COVID-19 Antibody Combination AZD7442
2021S.Korea stocks fall for 3rd day on caution over cenbank meetings
2021S.Korea stocks ease off 7-week high on caution ahead of Fed meeting
2021South Korean Stocks Rise as Investors Move Past Omicron Fears; LG Chem Adds 6%
2021Samsung Biologics, GreenLight Biosciences Enter Deal to Produce COVID-19 mRNA Vaccines
2021South Korean Stocks Fall for Fifth Session Over COVID-19 Variant Omicron Fears; Hyundai..
2021GreenLight Biosciences and Samsung Biologics Announce Collaboration to Build Capacity f..
2021South Korea’s Indexes Decline on Profit-Taking; Naver, LG Chem Decline over 2%
2021South Korean Stocks Break Three-Day Losses to Close Higher; Samsung Biologics Jumps 6% ..
2021MÄRKTE ASIEN/Etwas fester - Chinas Börsen hinken hinterher
2021MÄRKTE ASIEN/Uneinheitlich - Anleger warten auf Xi Jinping und Biden
2021Samsung Biologics Co.,Ltd. Reports Earnings Results for the Third Quarter and Nine Mont..
2021Samsung's Lee visits U.S ahead of likely $17 billion chip plant decision-media
2021S.Korea stocks end 1% higher on chip, biopharma boost, U.S. data in focus
2021South Korea Stocks Decline as Investors Eye US, China Inflation Data; Biopharma Stocks ..
2021S.Korean stocks end at near 1-month low as biopharma shares slump
2021Samsung Biologics Eyes Expansion in US, Europe
2021Private S.Korea firms plan $5.4 billion investment to create vaccine hub
2021South Korea Stocks Fall on Profit-Taking; Samsung Electronics Loses 1%
2021Samsung Biologics' Net Attributable Income Surges 135% in Q3
2021Samsung Biologics Co.,Ltd. Provides Revenue Guidance for the Year 2021
2021S.Korea approves Moderna's COVID-19 vaccine produced by Samsung Biologics
2021S.Korean stocks rebound on tech boost, easing China property woes
2021South Korean Stocks Slip on Slower Economy Growth in China, Highest Oil Prices in Years
2021South Korean Stocks Close Higher on Chip Shares' Gains; Samsung, SK Hynix Move Markets
2021SAMSUNG BIOLOGICS : Enzolytics Sign Deal for Anti-HIV, Anti-COVID-19 Monoclonal Antibody T..
2021Enzolytics Inc. and Samsung Biologics Co., Ltd. Announce Development and Manufacturing ..
2021Samsung Biologics showcases its newest CDO process platform, S-Cellerate™, at BPI 2021,..
2021Biogen, Samsung Bioepis Get FDA OK for Lucentis Biosimilar
2021South Korea Stocks Rise on Upbeat August US Retail Sales; Samsung Electronics Adds 1%
2021Samsung Biologics Joins Frontier 1.5D Project as Part of 2050 Carbon Neutral Initiative
2021KOSPI COMPOSITE INDEX : South Korea Stocks Gain Marginally as Investors' Await US Fed Chie..
2021MARKET CHATTER : Samsung Biologics Eyes Inaugural Public Bond Offering
2021SAMSUNG BIOLOGICS : European Commission Grants Marketing Approval to Samsung Bioepis' Luce..
2021Samsung invertirá 206.000 millones de dólares en los próximos tres años
2021Samsung to invest $206 bln by 2023 for post-pandemic growth
2021S.Korean stocks end at over four-month low on taper, virus fears
2021SAMSUNG BIOLOGICS : leader returns to court a week after being released
2021MARKET CHATTER : Samsung Bioepis' Biosimilar Sales Globally Surge 30% in H1
2021S.Korea pledges nearly $2 bln to become major COVID-19 vaccine producer
2021SAMSUNG BIOLOGICS' : Net Profit Surges over 130% in Q2
2021Samsung Biologics Co.,Ltd. Provides Dividend Guidance for the Year 2021
2021Samsung Biologics Co.,Ltd. Reports Earnings Results for the Second Quarter Ended June 3..
2021Samsung Biologics Signs Strategic Partnership Agreement with Kineta, Inc for Anti-VISTA..
2021S.Korea in talks with mRNA vaccine makers to make up to 1 bln doses -govt official
2021S.Korea in talks with mRNA vaccine makers to make up to 1 bln doses -govt official
2021MARKET CHATTER : Overseas, Institutional Investors Focus on Stocks that May Gain from Vacc..
2021MARKET CHATTER : Samsung Biologics Signs $269 Million Drug Manufacturing Deal with Gilead ..
2021S.Korean stocks end lower, investors look to U.S. inflation data
2021MARKET CHATTER : Samsung Biologics, Israel's KAHR Medical Enter CDMO Deal for Cancer Drug
2021Samsung Biologics and KAHR Medical Announce Development and Manufacturing Agreement for..
2021Moderna plans mix of COVID-19 vaccine doses with new Lonza deal
2021SAMSUNG BIOLOGICS : South Korea's Samsung Biologics to add mRNA vaccine production line
2021Samsung Biologics Announces to Add mRNA Vaccine Drug Substance Manufacturing Suite to E..
2021MODERNA : and Samsung Biologics Announce Agreement for Fill-Finish Manufacturing of Modern..
2021Samsung Biologics to Manufacture Moderna's COVID-19 Vaccine
2021MÄRKTE ASIEN/Aktien mehrheitlich im Plus - Seoul von Technikwerten gedrückt
2021Samsung BioLogics shares ease after jumping on vaccine deal
2021U.S. vaccine makers agree to produce more COVID-19 vaccines in South Korea
1  2  3  4Suiv.
Prochain événement sur SAMSUNG BIOLOGICS CO.,LTD.